CANDRIAM S.C.A. Global Blood Therapeutics, Inc. Transaction History

CANDRIAM S.C.A. portfolio value:

$24.58M
portfolio value

CANDRIAM S.C.A. quarter portfolio value change:

+113.15%
quarter

Global Blood Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -53.71% -418.73K shares -328K $68.1 360.95K
Q2 2022 share Increase +3.04% 22.98K shares -1.30M $31.95 779.69K
Q1 2022 share Increase +16.71% 108.36K shares 7.23M $34.64 756.70K
Q4 2021 share Increase +94.09% 314.29K shares 10.46M $29.86 648.33K
Q3 2021 share Increase +70.14% 137.71K shares 1.63M $25.48 334.04K
Q2 2021 share Increase 0.00% 196.33K shares 6.87M $35.02 196.33K
Q3 2020 share Decrease -100.00% -67.84K shares -4.28M $55.14 0
Q2 2020 share Increase +50.76% 22.84K shares 786K $63.13 67.84K
Q1 2020 share 0.00% 0 shares -80K $51.09 45K
Q4 2019 share Increase 0.00% 45K shares 3.57M $79.49 45K
Q1 2019 share Decrease -100.00% -96K shares -3.94M $52.93 0
Q4 2018 share Decrease -41.46% -68K shares -2.29M $41.05 96K
Q3 2018 share Increase +80.22% 73K shares 2.11M $38 164K
Q2 2018 share Increase +18.18% 14K shares 394K $45.2 91K
Q1 2018 share Decrease -28.04% -30K shares -491K $48.3 77K
Q4 2017 share Increase +10.31% 10K shares 1.19M $39.35 107K
Q3 2017 share Increase +16.87% 14K shares 742K $31.05 97K
Q2 2017 share Increase +7.79% 6K shares -568K $27.35 83K
Q1 2017 share 0.00% 0 shares 1.72M $36.85 77K
Q4 2016 share Increase +28.33% 17K shares -270K $14.45 77K
Q3 2016 share Increase +71.43% 25K shares 802K $23.05 60K
Q2 2016 share Increase 0.00% 35K shares 581K $16.59 35K